Selected article for: "cell target and SARS CoV cell response"

Author: Hasan, Amal; Al-Mulla, Mohammad R.; Abubaker, Jehad; Al-Mulla, Fahd
Title: Early insight into antibody-dependent enhancement after SARS-CoV-2 mRNA vaccination
  • Cord-id: jlzmdk9t
  • Document date: 2021_9_20
  • ID: jlzmdk9t
    Snippet: Current vaccines, which induce a B-cell-mediated antibody response against the spike protein of SARS-CoV-2, have markedly reduced infection rates. However, the emergence of new variants as a result of SARS-CoV-2 evolution requires the development of novel vaccines that are T-cell-based and that target mutant-specific spike proteins along with ORF1ab or nucleocapsid protein. This approach is more accommodative in inducing highly neutralizing antibodies, without the risk of antibody-dependent enha
    Document: Current vaccines, which induce a B-cell-mediated antibody response against the spike protein of SARS-CoV-2, have markedly reduced infection rates. However, the emergence of new variants as a result of SARS-CoV-2 evolution requires the development of novel vaccines that are T-cell-based and that target mutant-specific spike proteins along with ORF1ab or nucleocapsid protein. This approach is more accommodative in inducing highly neutralizing antibodies, without the risk of antibody-dependent enhancement, as well as memory CD8(+)T-cell immunity.

    Search related documents:
    Co phrase search for related documents